Concepedia

Landon M. Klein

LM

Statistics

Publications

5

Citations

230

H-Index

5

Active since

2014

Affiliations

University of California San Diego(Current)

Liverpool John Moores University

University of North Carolina at Chapel Hill

University of the Sciences

VA San Diego Healthcare System

Landon M. Klein is an author at University of California San Diego specializing in pharmacology, neuropharmacology, and medicine.

Publications per year

2014–2020

5

Publications

5

<i>N</i>-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT<sub>2</sub>Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues

David E. Nichols, Maria F. Sassano, Adam L. Halberstadt et al. · ACS Chemical Neuroscience · 2014 · 81 citations · Full text

, , +15

Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM‐775)

Simon D. Brandt, Pierce V. Kavanagh, Brendan Twamley et al. · Drug Testing and Analysis · 2017 · 56 citations · Full text

, , +13

Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs

Landon M. Klein, Nicholas V. Cozzi, Paul F. Daley et al. · Neuropharmacology · 2018 · 43 citations · Full text

, , +17

Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)

Adam L. Halberstadt, Landon M. Klein, Muhammad Chatha et al. · Psychopharmacology · 2018 · 25 citations · Full text

, , +6

Acute serotonin 2A receptor activation impairs behavioral flexibility in mice

Dionisio A. Amodeo, Omron Hassan, Landon M. Klein et al. · Behavioural Brain Research · 2020 · 25 citations · Full text

, , +15

1–5 of 5